questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Récepteurs de surface cellulaire
Récepteurs immunologiques
Intégrines
Intégrines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Attention Deficit and Disruptive Behavior Disorders
Diagnostic
5
Intégrines
Tests génétiques
Cytométrie en flux
Immunofluorescence
Imagerie moléculaire
Intégrines
Marqueurs tumoraux
Intégrines
Symptômes
5
Troubles de la coagulation
Intégrines
Cicatrisation
Migration cellulaire
Douleur articulaire
Arthrite
Maladies cutanées
Épidermolyse bulleuse
Prévention
5
Prévention
Mode de vie sain
Vaccination
Réponse immunitaire
Exercice physique
Santé cellulaire
Alimentation
Antioxydants
Traitements
5
Thérapies biologiques
Maladies auto-immunes
Médicaments anti-inflammatoires
Intégrines
Thérapie génique
Intégrines
Greffes d'organes
Rejet de greffe
Complications
5
Infections
Maladies auto-immunes
Maladies cardiovasculaires
Athérosclérose
Complications cutanées
Épidermolyse
Troubles neurologiques
Intégrines
Facteurs de risque
5
Facteurs de risque
Maladies auto-immunes
Vieillissement
Intégrines
Tabagisme
Santé cellulaire
Stress oxydatif
Intégrines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Intégrines : Questions médicales les plus fréquentes",
"headline": "Intégrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Intégrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-09",
"dateModified": "2025-05-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Intégrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Récepteurs immunologiques",
"url": "https://questionsmedicales.fr/mesh/D011971",
"about": {
"@type": "MedicalCondition",
"name": "Récepteurs immunologiques",
"code": {
"@type": "MedicalCode",
"code": "D011971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Intégrines alpha",
"alternateName": "Integrin alpha Chains",
"url": "https://questionsmedicales.fr/mesh/D039001",
"about": {
"@type": "MedicalCondition",
"name": "Intégrines alpha",
"code": {
"@type": "MedicalCode",
"code": "D039001",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha1",
"alternateName": "Integrin alpha1",
"url": "https://questionsmedicales.fr/mesh/D039423",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha1",
"code": {
"@type": "MedicalCode",
"code": "D039423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha2",
"alternateName": "Integrin alpha2",
"url": "https://questionsmedicales.fr/mesh/D039421",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha2",
"code": {
"@type": "MedicalCode",
"code": "D039421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha3",
"alternateName": "Integrin alpha3",
"url": "https://questionsmedicales.fr/mesh/D039422",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha3",
"code": {
"@type": "MedicalCode",
"code": "D039422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha4",
"alternateName": "Integrin alpha4",
"url": "https://questionsmedicales.fr/mesh/D039441",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha4",
"code": {
"@type": "MedicalCode",
"code": "D039441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha5",
"alternateName": "Integrin alpha5",
"url": "https://questionsmedicales.fr/mesh/D039482",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha5",
"code": {
"@type": "MedicalCode",
"code": "D039482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha6",
"alternateName": "Integrin alpha6",
"url": "https://questionsmedicales.fr/mesh/D039503",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha6",
"code": {
"@type": "MedicalCode",
"code": "D039503",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alphaV",
"alternateName": "Integrin alphaV",
"url": "https://questionsmedicales.fr/mesh/D039564",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alphaV",
"code": {
"@type": "MedicalCode",
"code": "D039564",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.900"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glycoprotéine-IIb de membrane plaquettaire",
"alternateName": "Platelet Membrane Glycoprotein IIb",
"url": "https://questionsmedicales.fr/mesh/D040201",
"about": {
"@type": "MedicalCondition",
"name": "Glycoprotéine-IIb de membrane plaquettaire",
"code": {
"@type": "MedicalCode",
"code": "D040201",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.950"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chaines bêta des intégrines",
"alternateName": "Integrin beta Chains",
"url": "https://questionsmedicales.fr/mesh/D039641",
"about": {
"@type": "MedicalCondition",
"name": "Chaines bêta des intégrines",
"code": {
"@type": "MedicalCode",
"code": "D039641",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD29",
"alternateName": "Integrin beta1",
"url": "https://questionsmedicales.fr/mesh/D019012",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD29",
"code": {
"@type": "MedicalCode",
"code": "D019012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine bêta3",
"alternateName": "Integrin beta3",
"url": "https://questionsmedicales.fr/mesh/D039661",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine bêta3",
"code": {
"@type": "MedicalCode",
"code": "D039661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.200.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine bêta4",
"alternateName": "Integrin beta4",
"url": "https://questionsmedicales.fr/mesh/D039663",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine bêta4",
"code": {
"@type": "MedicalCode",
"code": "D039663",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.200.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Récepteur cytoadhésine",
"alternateName": "Receptors, Cytoadhesin",
"url": "https://questionsmedicales.fr/mesh/D016024",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur cytoadhésine",
"code": {
"@type": "MedicalCode",
"code": "D016024",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.460"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Récepteur vitronectine",
"alternateName": "Receptors, Vitronectin",
"url": "https://questionsmedicales.fr/mesh/D019030",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur vitronectine",
"code": {
"@type": "MedicalCode",
"code": "D019030",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.460.870"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Récepteur du fibrinogène",
"alternateName": "Receptors, Fibrinogen",
"url": "https://questionsmedicales.fr/mesh/D039341",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur du fibrinogène",
"code": {
"@type": "MedicalCode",
"code": "D039341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.495"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récepteur fibronectine",
"alternateName": "Receptors, Fibronectin",
"url": "https://questionsmedicales.fr/mesh/D017469",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur fibronectine",
"code": {
"@type": "MedicalCode",
"code": "D017469",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.530"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récepteur adhésion leucocytaire",
"alternateName": "Receptors, Leukocyte-Adhesion",
"url": "https://questionsmedicales.fr/mesh/D016028",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur adhésion leucocytaire",
"code": {
"@type": "MedicalCode",
"code": "D016028",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récepteur VLA",
"alternateName": "Receptors, Very Late Antigen",
"url": "https://questionsmedicales.fr/mesh/D016029",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur VLA",
"code": {
"@type": "MedicalCode",
"code": "D016029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.850"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Intégrines",
"alternateName": "Integrins",
"code": {
"@type": "MedicalCode",
"code": "D016023",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Johanna Ivaska",
"url": "https://questionsmedicales.fr/author/Johanna%20Ivaska",
"affiliation": {
"@type": "Organization",
"name": "Turku Bioscience Center, University of Turku and Åbo Akademi University, FIN-20520 Turku, Finland; Department of Biochemistry, University of Turku, FIN-20520 Turku, Finland. Electronic address: joivaska@utu.fi."
}
},
{
"@type": "Person",
"name": "Jia Liu",
"url": "https://questionsmedicales.fr/author/Jia%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Shenzhen Jiake Biotechnology, Shenzhen, China."
}
},
{
"@type": "Person",
"name": "Michael Bachmann",
"url": "https://questionsmedicales.fr/author/Michael%20Bachmann",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Physiology and Metabolism, University of Geneva, Centre Médical Universitaire, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland."
}
},
{
"@type": "Person",
"name": "Vesa P Hytönen",
"url": "https://questionsmedicales.fr/author/Vesa%20P%20Hyt%C3%B6nen",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland."
}
},
{
"@type": "Person",
"name": "Bernhard Wehrle-Haller",
"url": "https://questionsmedicales.fr/author/Bernhard%20Wehrle-Haller",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Physiology and Metabolism, University of Geneva, Centre Médical Universitaire, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland bernhard.wehrle-haller@unige.ch."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Online parent training platform for complementary treatment of disruptive behavior disorders in attention deficit hyperactivity disorder: A randomized controlled trial protocol.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36301983",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0272516"
}
},
{
"@type": "ScholarlyArticle",
"name": "Examining attention-deficit/hyperactivity disorder and related behavioral disorders by fertility treatment exposure in a prospective cohort.",
"datePublished": "2023-03-25",
"url": "https://questionsmedicales.fr/article/36972758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.annepidem.2023.03.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Attachment in adolescents with attention deficit hyperactivity disorder and oppositional defiant disorder.",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/36342984",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12740/PP/OnlineFirst/130366"
}
},
{
"@type": "ScholarlyArticle",
"name": "The functioning of families of teens with attention deficit hyperactivity disorder and oppositional defiant disorder.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/37074835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12740/PP/OnlineFirst/128372"
}
},
{
"@type": "ScholarlyArticle",
"name": "Measurement Informed Care in Attention-Deficit/Hyperactivity Disorder (ADHD).",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/35697390",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chc.2022.03.010"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Récepteurs de surface cellulaire",
"item": "https://questionsmedicales.fr/mesh/D011956"
},
{
"@type": "ListItem",
"position": 6,
"name": "Récepteurs immunologiques",
"item": "https://questionsmedicales.fr/mesh/D011971"
},
{
"@type": "ListItem",
"position": 7,
"name": "Intégrines",
"item": "https://questionsmedicales.fr/mesh/D016023"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Intégrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Intégrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Intégrines",
"description": "Comment diagnostiquer une dysfonction des intégrines ?\nQuels examens sont utilisés pour évaluer les intégrines ?\nLes biopsies sont-elles utiles pour les intégrines ?\nPeut-on détecter les intégrines par imagerie ?\nQuels marqueurs sont associés aux intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Intégrines",
"description": "Quels symptômes indiquent une anomalie des intégrines ?\nLes troubles de la coagulation sont-ils liés aux intégrines ?\nComment les intégrines affectent-elles la cicatrisation ?\nLes douleurs articulaires peuvent-elles être liées aux intégrines ?\nY a-t-il des symptômes cutanés associés aux intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Intégrines",
"description": "Peut-on prévenir les troubles liés aux intégrines ?\nLes vaccinations influencent-elles les intégrines ?\nL'exercice physique affecte-t-il les intégrines ?\nLe stress a-t-il un impact sur les intégrines ?\nLes habitudes alimentaires influencent-elles les intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Intégrines",
"description": "Quels traitements ciblent les intégrines ?\nLes médicaments anti-inflammatoires aident-ils les intégrines ?\nLa thérapie génique peut-elle corriger les anomalies des intégrines ?\nLes greffes d'organes sont-elles affectées par les intégrines ?\nComment les intégrines sont-elles ciblées dans le cancer ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Intégrines",
"description": "Quelles complications peuvent survenir avec des anomalies des intégrines ?\nLes anomalies des intégrines peuvent-elles causer des cancers ?\nComment les intégrines affectent-elles la santé cardiovasculaire ?\nLes complications cutanées sont-elles fréquentes avec les intégrines ?\nLes troubles neurologiques peuvent-ils être liés aux intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Intégrines",
"description": "Quels facteurs augmentent le risque de troubles des intégrines ?\nL'âge influence-t-il la fonction des intégrines ?\nLe tabagisme affecte-t-il les intégrines ?\nLe diabète influence-t-il les intégrines ?\nLe stress oxydatif affecte-t-il les intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des intégrines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de sang peuvent aider à diagnostiquer les anomalies des intégrines."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les intégrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunofluorescence et la cytométrie en flux sont couramment utilisés pour évaluer les intégrines."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour les intégrines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent révéler des anomalies d'expression des intégrines dans les tissus."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les intégrines par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines techniques d'imagerie moléculaire peuvent visualiser l'expression des intégrines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux intégrines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme CD29 et CD49 peuvent être utilisés pour identifier les intégrines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie des intégrines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes d'adhésion cellulaire peuvent entraîner des inflammations et des infections récurrentes."
}
},
{
"@type": "Question",
"name": "Les troubles de la coagulation sont-ils liés aux intégrines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies des intégrines peuvent provoquer des troubles de la coagulation sanguine."
}
},
{
"@type": "Question",
"name": "Comment les intégrines affectent-elles la cicatrisation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les intégrines sont essentielles pour la migration cellulaire et la formation de nouveaux tissus lors de la cicatrisation."
}
},
{
"@type": "Question",
"name": "Les douleurs articulaires peuvent-elles être liées aux intégrines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements des intégrines peuvent contribuer à des douleurs articulaires et à l'arthrite."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux intégrines ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies des intégrines peuvent entraîner des maladies cutanées comme l'épidermolyse bulleuse."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux intégrines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certains troubles liés aux intégrines."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les intégrines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent moduler l'expression des intégrines, influençant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "L'exercice physique affecte-t-il les intégrines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la fonction des intégrines et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les intégrines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut altérer l'expression des intégrines, affectant la santé immunitaire."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les intégrines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut soutenir la fonction des intégrines et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les intégrines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques, comme les inhibiteurs d'intégrines, sont utilisées pour traiter certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les médicaments anti-inflammatoires aident-ils les intégrines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anti-inflammatoires peuvent réduire l'inflammation liée aux dysfonctionnements des intégrines."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle corriger les anomalies des intégrines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est une approche prometteuse pour corriger certaines anomalies des intégrines."
}
},
{
"@type": "Question",
"name": "Les greffes d'organes sont-elles affectées par les intégrines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les intégrines jouent un rôle clé dans l'acceptation ou le rejet des greffes d'organes."
}
},
{
"@type": "Question",
"name": "Comment les intégrines sont-elles ciblées dans le cancer ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements ciblant les intégrines peuvent inhiber la métastase et la progression tumorale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies des intégrines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections récurrentes, des troubles de la coagulation et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les anomalies des intégrines peuvent-elles causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans l'expression des intégrines sont associées à une augmentation du risque de cancer."
}
},
{
"@type": "Question",
"name": "Comment les intégrines affectent-elles la santé cardiovasculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dysfonctionnements des intégrines peuvent contribuer à des maladies cardiovasculaires et à l'athérosclérose."
}
},
{
"@type": "Question",
"name": "Les complications cutanées sont-elles fréquentes avec les intégrines ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies des intégrines peuvent entraîner des maladies cutanées graves comme l'épidermolyse."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques peuvent-ils être liés aux intégrines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les anomalies des intégrines et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles des intégrines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, des infections chroniques et des maladies auto-immunes augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la fonction des intégrines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut altérer l'expression et la fonction des intégrines dans le corps."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il les intégrines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut perturber l'expression des intégrines et affecter la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Le diabète influence-t-il les intégrines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut altérer la fonction des intégrines, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif affecte-t-il les intégrines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut endommager les intégrines et perturber leur fonction normale."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Turku Bioscience Center, University of Turku and Åbo Akademi University, FIN-20520 Turku, Finland; Department of Biochemistry, University of Turku, FIN-20520 Turku, Finland. Electronic address: joivaska@utu.fi.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Shenzhen Jiake Biotechnology, Shenzhen, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Department of Cell Physiology and Metabolism, University of Geneva, Centre Médical Universitaire, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Zoological Institute, Cell- and Neurobiology, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland.
Fimlab Laboratories, Biokatu 4, FI-33520 Tampere, Finland.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Department of Cell Physiology and Metabolism, University of Geneva, Centre Médical Universitaire, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland bernhard.wehrle-haller@unige.ch.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Zhong Yuan Academy of Biological Medicine, Liaocheng People's Hospital, No. 67 Dongchang West Road, Liaocheng 252000, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
Department of Orthopedics, Suzhou Ninth People's Hospital, Soochow University, Suzhou, Jiangsu, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China. yzeng@sibcb.ac.cn.
State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China. yzeng@sibcb.ac.cn.
Publications dans "Intégrines" :
2 publications dans cette catégorie
Affiliations :
School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China. jfchen@sibcb.ac.cn.
State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China. jfchen@sibcb.ac.cn.
Publications dans "Intégrines" :
Attention Deficit/Hyperactivity Disorder (ADHD) is associated with a diversity of impairments and Oppositional Defiant Disorder (ODD) is a very frequent comorbidity. Parent Training, as an evidence-ba...
Patients and their families will be screened upon their entry into the Research Center of Impulsivity and Attention (NITIDA) at UFMG-Brazil. Ninety families whose children are male, between 6-12 years...
This clinical trial intends to verify the effects of a new, online, model of an evidence-based intervention, which would allow a wider access in the Brazilian context....
Registered on Brazilian Registry of Clinical Trials (ReBEC). Number: RBR-6cvc85. July 24th (2020) 05:35 pm....
To evaluate whether underlying infertility and mode of conception are associated with childhood behavioral disorders....
Oversampling on fertility treatment exposure using vital records, the Upstate KIDS Study followed 2057 children (of 1754 mothers) from birth to 11 years. Type of fertility treatment and time to pregna...
Children conceived with fertility treatment (34%) did not have an increased risk of attention-deficit/hyperactivity disorder (aRR): 1.21; 95% CI: 0.88, 1.65), or conduct or oppositional defiant disord...
Underlying infertility or its treatment was not associated with risk of attention-deficit/hyperactivity disorder. Observations of increased anxiety or depression require replication....
To assess attachment styles among adolescents (13-16 years) with ADHD or ADHD and oppositional defiant disorders (ODD)....
The Parents and Peers Attachment (IPPA) and the Parent Bonding Questionnaire (PBI) were used in three groups of teenagers raised in biological families: (1) ADHD/ODD group (n = 40), (2) ADHD group (n ...
Parental attachment styles in the area of "Trust", "Communication" and "Alienation" (IPPA), and "Care" and "Control" (PBI) in the ADHD/ODD group differ significantly compared to the control group. Tee...
The attachment style is significantly different in adolescents diagnosed with ADHD and ODD than in adolescents with only ADHD. In the ADHD/ODD group and the ADHD group, unlike in the group of adolesce...
Comparison of the functioning of families of teens (13-16 years) with the diagnosis of attention deficit hyperactivity disorder (ADHD) or ADHD and oppositional defiant disorder (ODD)....
Assessment using the Family Assessment Questionnaire in three groups of adolescents growing up in biological families: (1) ADHD/ODD group (n = 40), (2) ADHD group (n = 40) and (3) group C (control gro...
Mothers, fathers and adolescents from the ADHD/ODD group scored significantly lower in all important aspects of family functioning compared to the control group. In the ADHD group, less favorable moth...
The functioning of families of patients with ADHD and ODD, and families of patients with ADHD significantly differs in all or most of the examined dimensions compared with families of people without d...
Measurement-informed care is a cornerstone of evidence-based practice and shared decision-making. A structured diagnostic interview specific to ADHD provides a globally agreed-on standard of evaluatio...
The diagnostic criteria for attention deficit hyperactivity disorder (ADHD) reflect the behavioural and functional outcomes of cognitive processes. Historically they have been based on external observ...
Emotional dysregulation (ED) manifesting as irritability or aggression produces appreciable impairment in children with attention deficit hyperactivity disorder and a main reason why they present for ...
The impairment of executive functions (EFs) in attention-deficit/hyperactivity disorder (ADHD) might vary from one individual to another, indicating high heterogeneity. Comorbidity may contribute to t...
This cohort study aimed to examine the association between prenatal exposure to illicit drugs and neurodevelopmental and disruptive behavioral disorders (DBD) in children aged 7-12 years, using data f...
Child-centered play therapy (CCPT) is a practical and recommended non-medication intervention for children with Attention-deficit/hyperactivity disorder (ADHD) but the mechanism in between is unclear....
This study proposed to examine the effectiveness of CCPT on neuropsychological deficits and behavioral symptoms in ADHD....
Participants with ADHD diagnosis were referred from senior child and adolescent psychiatrists, and typical developmental children (TD) were recruited from community as a control group. All participant...
Total 52 participants were recruited (17 with ADHD and 35 typically developed children, TD). The results showed that overall the ADHD groups had worse neuropsychological performance and more behaviour...